Led by Mark Bergman — 20+ years of hands-on medtech commercialization across the US and Canadian markets. From strategy to launch execution, we deliver results.
With over two decades of senior leadership across medical devices, diagnostics, and digital health, Mark Bergman brings a rare combination of clinical insight, commercial rigour, and deep regulatory knowledge to every engagement.
Holding a B.Sc., D.C., and MBA in Strategy and Marketing from the Schulich School of Business, Mark has held roles as Principal Consultant, Chief Revenue Officer, and VP of Sales and Marketing — giving Apex Medical an operator's perspective that pure advisory firms cannot replicate.
Our work spans the full commercialization continuum — from early-stage market assessment and regulatory navigation through to product launch, sales team development, and M&A support — primarily across the US and Canadian markets, with growing engagement from PE/VC firms and family offices.
Work With MarkEvery engagement is tailored to the specific regulatory, clinical, and commercial challenges of North American medtech — from first-in-market strategy to scaled commercial operations.
In-depth market analysis, competitive landscape assessment, and opportunity mapping for new launches and existing portfolios seeking US and Canadian expansion.
End-to-end go-to-market planning — pricing architecture, channel design, distribution strategy, and marketing programs built for North American adoption.
Dual-market navigation across FDA and Health Canada pathways, KOL recruitment, human factors testing support, and expert panel development.
Strategic identification, engagement, and cultivation of Key Opinion Leaders across key specialties — leveraging networks built over two decades of North American medtech work.
Recruiting, structuring, and training high-performing commercial teams — from role design and compensation models to onboarding programs tailored to medtech environments.
Strategic partner identification, due diligence support, and M&A advisory — including support for PE/VC and family office clients pursuing medtech acquisition or divestiture.
Identification and application support for government grants, innovation funding, and R&D programs in Canada and the US.
Apex Medical draws on a curated network of senior specialists across every critical function — giving clients full-service capability without the overhead of a large firm.
Health Canada and FDA submission expertise, quality system development, compliance strategy, and regulatory pathway assessment for medical devices and diagnostics.
HEOR strategy, payer landscape analysis, reimbursement pathway development, and value dossier creation to support coverage and market access across North America.
Medical device marketing, KOL engagement, clinical content development, and brand positioning tailored to both HCP and patient audiences.
Integration of AI-enabled tools into commercial and clinical workflows, digital health strategy, and technology assessment for medtech companies.
Sales team recruitment, structure design, compensation modeling, onboarding programs, and CRM implementation for medical device commercial organizations.
Commercial technology stack assessment, data analytics, and IT infrastructure advisory to support scalable medtech operations.
Live medtech and health technology news — updated automatically from leading industry sources.
Deep understanding of your product, goals, and the specific market dynamics you face in Canada and the US.
A tailored commercialization roadmap — regulatory, pricing, distribution, and clinical engagement.
Hands-on implementation alongside your team — KOL programs, stakeholder relationships, and market-entry activities.
Post-launch expansion, performance monitoring, and ongoing strategy optimization.
Whether you're preparing for a first launch, exploring M&A, or need a trusted commercialization partner across North America — Apex Medical is ready.